Position in CELC
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$17,121
+$2,160 QoQ
Shares Held
150
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in CELC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Financial Perspectives, Inc holds $818,923 across 15 Biotechnology names. CELC ranks #8 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
588 | $174,618 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
191 | $147,574 | |
| 3 | CRSP |
CRISPR Therapeutics AG
|
2,422 | $115,214 | |
| 4 | ARGX |
Argenx SE
|
145 | $105,886 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,155 | $103,375 | |
| 6 | INCY |
Incyte Corp
|
1,000 | $94,120 | |
| 7 | GMAB |
Genmab A/S
|
1,333 | $35,764 | |
| 8 | CELC |
Celcuity Inc.
This page
|
150 | $17,121 |
All Filings in CELC
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,121 | 150 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $14,961 | 150 | Shares | Sole | 2026-01-28 | |
| No filing history on record for this holder in this stock. | ||||||